Latigo Biotherapeutics Inc.

Last updated September 27, 2026

Favorite this organization

Organization details

Legal name: Latigo Biotherapeutics Inc.
Ownership: Public
Status: Active
Sector (GICS): Health Care
SIC code: 2834 — Pharmaceutical Preparations
Jurisdiction of incorporation: Delaware
Headquarters city: Thousand Oaks
Headquarters state / province: California
Headquarters country: United States
Fiscal year end: December
Ticker symbol: LTGO
Primary stock exchange: Nasdaq

Identifiers

SEC CIK: 0002056611
EIN: 83-2625838

Board of directors

Follow this board

Beth C. Seidenberg · Director Overboarded
Since 2026
James B. Tananbaum · Director
Since 2026
Kevin Raidy · Director
Since 2026
Nima Farzan · Director · President and CEO
Since 2026
Sara Bonstein · Director
Since 2026
Timothy P. Walbert · Director Overboarded
Since 2026
Todd N. Smith · Director
Since 2026

Chief executives

Nima Farzan · President and CEO

Since August 2026

Board connections

5 of this board's directors also sit on 13 other boards. 13 are in the same sector.

Shared director Other board Same sector

Sagimet Biosciences Inc. Same sector
via Beth C. Seidenberg and Timothy P. Walbert
Alumis Inc. Same sector
via James B. Tananbaum
Atara Biotherapeutics Inc. Same sector
via Beth C. Seidenberg
BioMarin Pharmaceutical Inc. Same sector
via Timothy P. Walbert
Century Therapeutics Inc. Same sector
via Timothy P. Walbert
Kardigan Inc. Same sector
via Timothy P. Walbert
Keros Therapeutics Inc. Same sector
via Nima Farzan
Kyverna Therapeutics Inc. Same sector
via Beth C. Seidenberg
Mirum Pharmaceuticals Inc. Same sector
via Timothy P. Walbert
Odyssey Therapeutics Inc. Same sector
via Timothy P. Walbert
Progyny Inc. Same sector
via Beth C. Seidenberg
Vera Therapeutics Inc. Same sector
via Beth C. Seidenberg
Xilio Therapeutics Inc. Same sector
via Sara Bonstein

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months: $5,040,000; 2 purchases by 2 insiders
Sold, last 12 months: $0; 0 sales by 0 insiders

Date	Insider	Transaction	Shares	Price	Value
Aug 10, 2026	Foresite Capital Fund VI LP 10% owner	Derivative conversion	+3,117,664	—	—
Aug 10, 2026	Beth C. Seidenberg Director, 10% owner	Derivative conversion	+938,979	—	—
Aug 10, 2026	James B. Tananbaum Director, 10% owner	Derivative conversion	+3,117,664	—	—
Aug 10, 2026	Westlake BioPartners GP I, LLC 10% owner	Derivative conversion	+938,979	—	—
Aug 10, 2026	5AM Partners VI, LLC 10% owner	Derivative conversion	+4,975,543	—	—
Aug 10, 2026	Sanofi 10% owner	Derivative conversion	+494,800	—	—
Aug 10, 2026	Foresite Capital Fund VI LP 10% owner	Derivative conversion	+445,320	—	—
Aug 10, 2026	Beth C. Seidenberg Director, 10% owner	Derivative conversion	+3,547,842	—	—
Aug 10, 2026	James B. Tananbaum Director, 10% owner	Derivative conversion	+445,320	—	—
Aug 10, 2026	Westlake BioPartners GP I, LLC 10% owner	Derivative conversion	+3,547,842	—	—
Aug 10, 2026	5AM Partners VI, LLC 10% owner	Derivative conversion	+2,350,419	—	—
Aug 10, 2026	Sanofi 10% owner	Derivative conversion	+177,978	—	—
Aug 10, 2026	Foresite Capital Fund VI LP 10% owner	Derivative conversion	+1,125,823	—	—
Aug 10, 2026	Beth C. Seidenberg Director, 10% owner	Derivative conversion	+1,027,635	—	—
Aug 10, 2026	James B. Tananbaum Director, 10% owner	Derivative conversion	+1,125,823	—	—

Peers

Compare boards

Organizations in the same sector, closest in location and size first.

3M Company NYSE: MMM · ST Paul, United States Organization ABVC BioPharma Inc. Nasdaq: ABVC · Fremont, United States Organization ACADIA Pharmaceuticals Inc. Nasdaq: ACAD · SAN Diego, United States Organization ADMA Biologics Inc Nasdaq: ADMA · Ramsey, United States Organization

Questions about Latigo Biotherapeutics Inc.

Who is the CEO of Latigo Biotherapeutics Inc.?

Nima Farzan has been Latigo Biotherapeutics Inc.'s President and CEO since August 2026.

How many directors are on Latigo Biotherapeutics Inc.'s board?

Latigo Biotherapeutics Inc.'s board has 7 directors: Beth C. Seidenberg, James B. Tananbaum, Kevin Raidy, Nima Farzan, Sara Bonstein, Timothy P. Walbert and Todd N. Smith.

Are Latigo Biotherapeutics Inc. insiders buying or selling shares?

Over the last 12 months, Latigo Biotherapeutics Inc. insiders bought $5.0 million of shares in 2 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

How is Latigo Biotherapeutics Inc. connected to…? → Spot something wrong? Report a correction

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="latigo-biotherapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

No reviews yet. Be the first to write one.